• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 导致的心包积液压塞性心肌炎,无呼吸系统症状:病例报告。

COVID-19 myopericarditis with cardiac tamponade in the absence of respiratory symptoms: a case report.

机构信息

Basingstoke and North Hampshire Hospital, Hampshire Hospitals Foundation Trust, Hampshire, United Kingdom.

出版信息

J Med Case Rep. 2021 Jan 25;15(1):31. doi: 10.1186/s13256-020-02618-z.

DOI:10.1186/s13256-020-02618-z
PMID:33494822
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7833446/
Abstract

BACKGROUND

Previous reports have shown various cardiac complications to be associated with COVID-19 including: myocardial infarction, microembolic complications, myocardial injury, arrythmia, heart failure, coronary vasospasm, non-ischemic cardiomyopathy, stress (Takotsubo) cardiomyopathy, pericarditis and myocarditis. These COVID-19 cardiac complications were associated with respiratory symptoms. However, our case illustrates that COVID-19 myopericarditis with cardiac tamponade can present without respiratory symptoms.

CASE PRESENTATION

A 58-year-old Caucasian British woman was admitted with fever, diarrhoea and vomiting. She developed cardiogenic shock and Transthoracic echocardiogram (TTE) found a pericardial effusion with evidence of cardiac tamponade. A nasopharyngeal swab showed a COVID-19 positive result, despite no respiratory symptoms on presentation. A pericardial drain was inserted and vasopressor support required on intensive treatment unit (ITU). The drain was removed as she improved, an antibiotic course was given and she was discharged on day 12.

CONCLUSIONS

Our case demonstrates that patients without respiratory symptoms could have COVID-19 and develop cardiac complications. These findings can aid timely diagnosis of potentially life-threatening COVID-19 myopericarditis with cardiac tamponade.

摘要

背景

先前的报告表明,COVID-19 可引起多种心脏并发症,包括:心肌梗死、微栓塞并发症、心肌损伤、心律失常、心力衰竭、冠状动脉痉挛、非缺血性心肌病、应激性(Takotsubo)心肌病、心包炎和心肌炎。这些 COVID-19 心脏并发症与呼吸系统症状相关。然而,我们的病例表明,COVID-19 心肌炎伴心包填塞可在无呼吸系统症状的情况下发生。

病例介绍

一名 58 岁的白人英国女性因发热、腹泻和呕吐而入院。她出现心源性休克,经经胸超声心动图(TTE)发现心包积液并伴有心包填塞证据。鼻拭子检测结果显示 COVID-19 阳性,尽管就诊时无呼吸系统症状。置入心包引流管并在重症监护病房(ICU)给予升压支持。随着病情的改善,引流管被移除,给予抗生素治疗,患者于第 12 天出院。

结论

我们的病例表明,无呼吸系统症状的患者可能患有 COVID-19 并发生心脏并发症。这些发现有助于及时诊断可能危及生命的 COVID-19 心肌炎伴心包填塞。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7614/7836451/a9aa8fc7942b/13256_2020_2618_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7614/7836451/f0c860508a04/13256_2020_2618_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7614/7836451/f9c7c10c96de/13256_2020_2618_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7614/7836451/e5348f349300/13256_2020_2618_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7614/7836451/ee3dab25b582/13256_2020_2618_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7614/7836451/a9aa8fc7942b/13256_2020_2618_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7614/7836451/f0c860508a04/13256_2020_2618_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7614/7836451/f9c7c10c96de/13256_2020_2618_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7614/7836451/e5348f349300/13256_2020_2618_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7614/7836451/ee3dab25b582/13256_2020_2618_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7614/7836451/a9aa8fc7942b/13256_2020_2618_Fig5_HTML.jpg

相似文献

1
COVID-19 myopericarditis with cardiac tamponade in the absence of respiratory symptoms: a case report.COVID-19 导致的心包积液压塞性心肌炎,无呼吸系统症状:病例报告。
J Med Case Rep. 2021 Jan 25;15(1):31. doi: 10.1186/s13256-020-02618-z.
2
A rare presentation of a patient with COVID-19: Cardiac tamponade.一名新冠肺炎患者的罕见表现:心脏压塞。
Turk Kardiyol Dern Ars. 2020 Oct;48(7):703-706. doi: 10.5543/tkda.2020.56727.
3
Acute Myopericarditis with Pericardial Effusion and Cardiac Tamponade in a Patient with COVID-19.一名新冠肺炎患者出现急性心肌心包炎伴心包积液和心脏压塞
Am J Case Rep. 2020 Jul 1;21:e925554. doi: 10.12659/AJCR.925554.
4
Pediatric COVID-19 and Pericarditis Presenting With Acute Pericardial Tamponade.小儿新冠病毒肺炎合并心包炎伴急性心包填塞
World J Pediatr Congenit Heart Surg. 2020 Nov;11(6):802-804. doi: 10.1177/2150135120949455. Epub 2020 Sep 10.
5
Myopericarditis with predominantly right ventricular involvement with normal B-type natriuretic peptide and cardiac tamponade as the initial manifestation of systemic lupus erythematosus.以右心室为主受累的心肌心包炎伴B型利钠肽正常及心脏压塞作为系统性红斑狼疮的初始表现
Lupus. 2014 Aug;23(9):935-8. doi: 10.1177/0961203314530486. Epub 2014 Apr 4.
6
Takotsubo cardiomyopathy complicated by cardiac tamponade due to non-hemorrhagic pericardial effusion: a case report.因非出血性心包积液并发心脏压塞的 Takotsubo 心肌病:一例报告。
BMC Cardiovasc Disord. 2020 Feb 6;20(1):67. doi: 10.1186/s12872-020-01377-5.
7
Cardiogenic shock following cardiac tamponade and Takotsubo in COVID-19.COVID-19 导致的心包填塞和心尖球形综合征并发心原性休克。
Future Cardiol. 2021 Jul;17(4):631-635. doi: 10.2217/fca-2020-0115. Epub 2020 Oct 20.
8
Myopericarditis with cardiac tamponade caused by Neisseria meningitidis serogroup W135.W135群脑膜炎奈瑟菌引起的伴有心脏压塞的心肌心包炎。
Eur J Clin Microbiol Infect Dis. 1988 Jun;7(3):403-4. doi: 10.1007/BF01962346.
9
Hemorrhagic pericardial effusion leading to cardiac tamponade, as presenting feature of COVID-19 in a young man: a case report.以年轻男性为首发表现的 COVID-19 导致的心包积血、心脏压塞:1 例报告。
Acta Biomed. 2020 Nov 10;91(4):e2020146. doi: 10.23750/abm.v91i4.10183.
10
Pericardial effusion and cardiac tamponade requiring pericardial window in an otherwise healthy 30-year-old patient with COVID-19: a case report.一名原本健康的30岁新冠肺炎患者出现心包积液和心脏压塞,需行心包开窗引流术:病例报告
J Med Case Rep. 2020 Sep 9;14(1):158. doi: 10.1186/s13256-020-02467-w.

引用本文的文献

1
Systematic review of case reports on COVID-19 associated myocarditis: a discussion on treatments.关于 COVID-19 相关心肌炎的病例报告的系统回顾:关于治疗方法的讨论。
Virol J. 2024 Oct 9;21(1):252. doi: 10.1186/s12985-024-02499-4.
2
Medical History and Laboratory Tests are Crucial to Elucidate the Triggers of Takotsubo in COVID-19.病史和实验室检查对于阐明COVID-19中Takotsubo综合征的触发因素至关重要。
Eur J Case Rep Intern Med. 2023 Dec 22;11(1):004223. doi: 10.12890/2023_004223. eCollection 2024.
3
Acute Pericarditis as the Primary Presentation of COVID-19 Infection followed by Guillain-Barre Syndrome in a Healthy Young Man: A Case Report.

本文引用的文献

1
COVID-19 (SARS-CoV-2) and the Heart - An Ominous Association.新型冠状病毒肺炎(严重急性呼吸综合征冠状病毒2)与心脏——一种不祥的关联。
Cardiovasc Revasc Med. 2020 Aug;21(8):946-949. doi: 10.1016/j.carrev.2020.05.009. Epub 2020 May 15.
2
COVID-19 myopericarditis: It should be kept in mind in today's conditions.COVID-19 导致的心包炎:在当下的情况下,应牢记这一点。
Am J Emerg Med. 2020 Jul;38(7):1547.e5-1547.e6. doi: 10.1016/j.ajem.2020.04.080. Epub 2020 Apr 28.
3
Cardiac Tamponade Secondary to COVID-19.新型冠状病毒肺炎继发的心包填塞
一名健康青年男性以急性心包炎为新冠病毒感染的首发表现,随后并发吉兰-巴雷综合征:病例报告
Open Respir Med J. 2022 Dec 12;16:e187430642210190. doi: 10.2174/18743064-v16-e221020-2022-8. eCollection 2022.
4
Subacute Cardiac Tamponade in a COVID-19 Patient Despite Negative Testing.一名新冠病毒检测呈阴性的患者出现亚急性心脏压塞
Cureus. 2022 Sep 12;14(9):e29090. doi: 10.7759/cureus.29090. eCollection 2022 Sep.
5
A Systematic Review of COVID-19 and Pericarditis.新型冠状病毒肺炎与心包炎的系统评价
Cureus. 2022 Aug 12;14(8):e27948. doi: 10.7759/cureus.27948. eCollection 2022 Aug.
6
COVID-19 Myopericarditis With Pericardial Effusion Complicated With Cardiac Tamponade and Rhabdomyolysis.新型冠状病毒肺炎相关性心肌心包炎伴心包积液并发心脏压塞及横纹肌溶解症
Cureus. 2022 Jul 26;14(7):e27291. doi: 10.7759/cureus.27291. eCollection 2022 Jul.
7
Acute Polyserositis with Cardiac Tamponade and Bilateral Refractory Pleural Effusion after ChAdOx1 nCoV-19 Vaccination.ChAdOx1 nCoV-19疫苗接种后出现急性多浆膜炎伴心脏压塞和双侧难治性胸腔积液
Vaccines (Basel). 2022 Aug 10;10(8):1286. doi: 10.3390/vaccines10081286.
8
Network Pharmacology and Molecular Docking Elucidate the Underlying Pharmacological Mechanisms of the Herb in Treating Pneumonia Caused by SARS-CoV-2.网络药理学与分子对接阐明该草药治疗新型冠状病毒肺炎的潜在药理机制
Viruses. 2022 Jul 21;14(7):1588. doi: 10.3390/v14071588.
9
Life-Threatening Cardiac Tamponade Secondary to COVID-19 Treated with Uniportal Video-Assisted Thoracoscopic Surgery: A Case Report.COVID-19 所致危及生命的心包填塞采用单孔电视辅助胸腔镜手术治疗:病例报告。
Am J Case Rep. 2022 Apr 9;23:e935839. doi: 10.12659/AJCR.935839.
10
Pericardial Cytokine "Storm" in a COVID-19 Patient: the Confirmation of a Hypothesis.COVID-19 患者的心包细胞因子“风暴”:假设的验证。
Inflammation. 2022 Feb;45(1):1-5. doi: 10.1007/s10753-021-01563-3. Epub 2021 Sep 17.
JACC Case Rep. 2020 Jul 15;2(9):1326-1330. doi: 10.1016/j.jaccas.2020.04.009. Epub 2020 Apr 23.
4
Life-threatening cardiac tamponade complicating myo-pericarditis in COVID-19.危及生命的心包填塞使新冠肺炎患者的心肌心包炎病情复杂化。
Eur Heart J. 2020 Jun 7;41(22):2130. doi: 10.1093/eurheartj/ehaa253.
5
Potential Effects of Coronaviruses on the Cardiovascular System: A Review.冠状病毒对心血管系统的潜在影响:综述。
JAMA Cardiol. 2020 Jul 1;5(7):831-840. doi: 10.1001/jamacardio.2020.1286.
6
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19).新冠肺炎(COVID-19)患者的心脏受累。
JAMA Cardiol. 2020 Jul 1;5(7):819-824. doi: 10.1001/jamacardio.2020.1096.
7
Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic.心血管考虑因素在 COVID-19 大流行期间的患者、医护人员和卫生系统。
J Am Coll Cardiol. 2020 May 12;75(18):2352-2371. doi: 10.1016/j.jacc.2020.03.031. Epub 2020 Mar 19.